Singapore: Genetic Technologies revealed that a story highlighting the BREVAGen test and its successful US launch featur...
Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is em...
Singapore: Starpharma's vice president, Dr Malcolm McColl, has been appointed CEO, Viralytics. Prior to this, Dr McCol...
Singapore: Bluechiip, which has developed a unique temperature sensing and tracking solution initially for cryogenic sa...
Singapore: HeartWare International, a leading innovator of less invasive, miniaturized circulatory support technologies...
Singapore: Bionomics has been advised by its licensee, Ironwood Pharmaceuticals, that following the submission of an In...
Singapore: Australia's Therapeutic Goods Administration (TGA) has identified errors in its internal reports regarding t...
Singapore: Australia-based Telesso Technologies raised $6.5 million capital in connection with its acquisition of Mimeti...
Singapore: South Korea is the fourth largest contributor to the lifescience market in the region. • Korean Minis...
Singapore: The number of Australians with age-related macular degeneration (AMD) is expected to grow to over 1.7 million...
Singapore: Australian drug discovery firm, Bionomics, has received positive results in the phase I clinical trial of its...
Singapore: Australia-based Viralytics in its ongoing US-based phase II melanoma trial of its virotherapy candidate Cava...
Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, ant...
Singapore: Germany-headquartered Medigene and SynCore Biotechnology, a member of Sinphar Pharmaceutical Group, have expa...
Singapore: Canada-based Kane Biotech, which is engaged in the development and commercialization of products that prevent...
Singapore: Ministers from Australia and New Zealand attended the second meeting of the Australia New Zealand Therapeutic...
Singapore: Aerocrine received marketing approval for its airway inflammation monitor, NIOX MINO and NIOX MINO Test Kit, ...
Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market fol...
Singapore: Australia-based, TGR BioSciences, a life sciences company focused on the development of rapid, high sensitivi...
Singapore: Alchemia, Australia based drug discovery and development company, has appointed Mr. Santo J. Costa as non-exe...
Singapore: Australian company Bionomics and Merck Serono, a division of Merck, Darmstadt Germany, have mutually ended t...
Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the...
Singapore: The Supreme Court of Victoria has approved the scheme of arrangement between Biota Holdings and the holders o...
Singapore: Eisai Australia, a subsidiary of the Japanese firm Eisai, has received approval from the Australian Departme...
Singapore: GI Dynamics has initiated its US multicenter pivotal clinical trial of EndoBarrier, the Endo trial, for the ...
